首页> 外国专利> Pharmaceutical Product comprising a synergistic amount of a selective antagonist of NMDA forebrain and a compound capable of increasing the feedback excitation of a Nucleus LateraL ventral Thalamus to Cortex for the Treatment

Pharmaceutical Product comprising a synergistic amount of a selective antagonist of NMDA forebrain and a compound capable of increasing the feedback excitation of a Nucleus LateraL ventral Thalamus to Cortex for the Treatment

机译:药物产品,该药物包含协同量的NMDA前脑选择性拮抗剂和一种能够增加髓核腹侧丘脑对皮质皮层的反馈激发的化合物,以进行治疗

摘要

The invention refers to a procedure for treating Parkinson's disease, which relates to mammals with Parkinson's disease. It combines the selective NMDA diagonal in the forebrain with a compound that can increase stimulating feedback from the window core of the talamo river. The invention also relates to compound drugs containing synergistic effects.
机译:本发明涉及治疗帕金森氏病的方法,其涉及患有帕金森氏病的哺乳动物。它结合了前脑中的选择性NMDA对角线和可增加塔拉莫河窗核心刺激性反馈的化合物。本发明还涉及具有协同作用的复合药物。

著录项

  • 公开/公告号CO4700422A1

    专利类型

  • 公开/公告日1998-12-29

    原文格式PDF

  • 申请/专利权人 PFIZER INC.;

    申请/专利号CO19960026135

  • 发明设计人 CHENARD BERTRAND L.;

    申请日1996-05-23

  • 分类号A61K31/45;

  • 国家 CO

  • 入库时间 2022-08-22 02:28:03

相似文献

  • 专利
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号